SLC1A2 and major depressive disorder: They found evidence of astrocyte dysfunctions in the LC region in individuals with MDD, which included reduced expression levels of SLC1A3, SLC1A2 and GFAP, together with lower GFAP protein levels, and reduced density of GFAP-positive astrocytes.